Elevance Health Plunges 6.17% on Lowered Earnings Outlook

On May 13, 2025, Elevance Health's stock experienced a significant drop of 6.17% in pre-market trading, indicating a notable shift in investor sentiment.

Analysts have revised their expectations for Elevance Health's second-quarter earnings, with K. Dey from Zacks Research now projecting earnings per share of $9.36, down from the previous estimate of $9.85. This adjustment reflects a more cautious outlook on the company's financial performance.

Zacks' proprietary data rates Elevance Health as a Zacks Rank 3, suggesting an inline return for investors. This rating is based on a comprehensive analysis of the company's financial health and market position, providing a balanced view of its potential for growth.

Elevance Health has also provided guidance for its 2025 adjusted earnings per share from continuing operations, expecting a range of $4.85 to $5.10. This guidance offers investors a clearer picture of the company's anticipated financial performance for the year, helping to manage expectations and inform investment decisions.